topSkip to main content

Menu, Secondary

Menu Trigger

Menu

Parkinson's & Epilepsy

Stanford researchers set out to test a seminal theory of Parkinson’s disease and several related conditions. What they found is more complex than anyone had imagined.
Smartphone software and technology can accurately track the severity of Parkinson’s disease symptoms, a new study shows.
Researchers have developed an algorithm that can be used to analyze a patient's medical history and predict whether the patient is at risk for developing Parkinson’s disease.
A new study at Michigan State University provides further evidence that a simple scratch-and-sniff test could predict Parkinson’s disease even earlier than previously thought.
Michigan State University scientists now have early proof that an antidepressant drug that’s been around for more than 50 years could slow the progression of Parkinson’s.
A USC researcher is using a novel technique to deliver very large molecules to treat cancer, Parkinson’s and Alzheimer’s.
Fecal transplants are increasingly being used as the treatment of last resort for certain infections in the human gut and have had remarkable success treating the nursing home and hospital-acquired scourge, Clostridium difficile colitis, an infectious diarrhea that often follows antibiotic treatment.
Scott Grafton helps develop a theory of compound movement that highlights a tradeoff between efficiency and computational cost.
Cognitive impairment is one of the core symptoms of multiple sclerosis (MS)—and one of its most troubling concerns for many people with the condition. Now, a new study from NYU Langone Medical Center may provide hope for symptomatic relief for some of the cognitive issues associated with the neurological disease.